Frank McCormick's Net Worth
$47.2 Million
Who is Frank McCormick?
Frank McCormick has an estimated net worth of $47.2 Million. This is based on reported shares across multiple companies, which include EXELIXIS INC, BridgeBio Pharma, Inc., ADURO BIOTECH, INC., and Olema Pharmaceuticals, Inc..
SEC CIK
Frank McCormick's CIK is 0001257809
Past Insider Trading and Trends
2019 was Frank McCormick's most active year for acquiring shares with 6 total transactions. Frank McCormick's most active month to acquire stocks was the month of April. 2019 was Frank McCormick's most active year for disposing of shares, totalling 16 transactions. Frank McCormick's most active month to dispose stocks was the month of November. 2003 saw Frank McCormick paying a total of $207,250.00 for 25,000 shares, this is the most they've acquired in one year. In 2020 Frank McCormick cashed out on 252,891 shares for a total of $4,275,768.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EXELIXIS, INC. (EXEL) Snapshot price: $25.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
No matching records found |
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $30.7
Chairman Oncology
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| -13.74% | -100.00K |
$42.06 | -$4,206,000.00 | 627.69K |
Scheduled
|
Dec 26
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -7.69% | -100.00K |
$42.76 | -$4,275,768.84 | 1.2M |
Nov 13
| |||
Form 4
| +3.09% | 39.04K |
—
|
—
| 1.3M |
May 19
| |||
Form 4
| -3.79% | -100.00K |
$36.86 | -$3,755,379.27 | 2.54M |
Scheduled
|
Dec 27 - Dec 30
| ||
Form 4
|
∞
| 1.36M |
—
|
—
| 1.36M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ADURO BIOTECH, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Olema Pharmaceuticals, Inc. (OLMA) Snapshot price: $11.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +390.37% | 219.22K |
—
|
—
| 275.37K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18 - Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |